Citations

Showing 10 of 108119 citations.

Editorial: autoimmune diseases in microscopic colitis—how does this information help clinicians?
Pardi, Darrell S. , Pardi, D S

Mayo Clinic

Alimentary Pharmacology & Therapeutics | October 26, 2021 | Volume: 54 | Issue: 10 | Pages: 1357-1358

10.1111/apt.16637 | PMID 34699102 Get It

LINKED CONTENTThis article is linked to Wildt et al paper. To view this article, visit https://doi.org/10.1111/apt.16614
Comparative study of therapy‐related and de novo adult b‐cell acute lymphoblastic leukaemia
Rahman, Zaid H. Abdel , Parrondo, Ricardo , Wieczorek, Mikolaj A. , Miller, Kevin C. , Sproat, Lisa Z., Murthy, Hemant S. , Kharfan‐Dabaja, Mohamed A. , Peterson, Jess F. , Hoppman, Nicole L., Litzow, Mark R. , Greipp, Patricia T. , Foran, James M. , Rahman, Zaid Abdel , Abdel Rahman, Zaid H , Parrondo, Ricardo D , Wieczorek, Mikolaj, Murthy, Hemant S , Kharfan-Dabaja, Mohamed A , Hoppman, Nicole, Foran, James M , Peterson, Jess F , Greipp, Patricia T , Miller, Kevin C , Heckman, Michael G. , Alkhateeb, Hassan B. , Hogan, William J. , Baughn, Linda B. , Ketterling, Rhett P.

Mayo Clinic

British Journal of Haematology | October 26, 2021 | Volume: 196 | Issue: 4 | Pages: 963-968

10.1111/bjh.17906 | PMID 34697797 Get It

SummaryWe report a comparative analysis of patients with therapy‐related acute lymphoblastic leukaemia (tr‐ALL) vs de novo ALL. We identified 331 patients with B‐ALL; 69 (21%) were classified as tr‐ALL. The most common prior malignancies were breast (23·2%) and plasma cell disorders (20·3%). Patients with tr‐ALL were older (median 63·2 vs. 46·2 years, P < 0.001), more often female (66·7% vs. 43·5%, P < 0·001), and more likely to have hypodiploid cytogenetics (18·8% vs. 5·0%, P < 0·001). In multivariable analysis, patients with tr‐ALL were less likely to achieve complete remission [odds ratio (OR) = 0·16, P < 0·001] and more likely to be minimal residual disease‐positive (OR = 4·86, P = 0·01) but had similar OS after diagnosis and allo‐haematopoietic cell transplantation.
Experience and consensus on stimulation of the anterior nucleus of thalamus for epilepsy
Fasano, Alfonso , Eliashiv, Dawn, Herman, Susan T. , Lundstrom, Brian N. , Polnerow, Dara, Henderson, Jaimie M. , Fisher, Robert S. , Lundstrom, Brian Nils , Fisher, Robert

Mayo Clinic

Epilepsia | October 26, 2021 | Volume: 62 | Issue: 12 | Pages: 2883-2898

10.1111/epi.17094 | PMID 34697794 Get It

Abstract Deep brain stimulation of the anterior nuclei of thalamus (ANT‐DBS) is effective for reduction of seizures, but little evidence is available to guide practitioners in the practical use of this therapy. In an attempt to fill this gap, a questionnaire with 37 questions was circulated to 578 clinicians who were either engaged in clinical trials of or known users of DBS for epilepsy, with responses from 141, of whom 58.2% were epileptologists and 28.4% neurosurgeons. Multiple regions of the world were represented. The survey found that the best candidates for DBS were considered those with temporal or frontal seizures, refractory to at least two medicines. Motivations for renewing therapy upon battery depletion were reduced convulsive, impaired awareness, and severe seizures and improved quality of life. Targeting of leads mainly was by magnetic resonance imaging, sometimes with intraoperative imaging or microelectrode recording. The majority used transventricular approaches. Stimulation parameters mostly imitated the SANTE study parameters, except for initial stimulation amplitudes in the 2–3‐V or ‐mA range, versus 5 V in the SANTE study. Stimulation intensity was most often increased or reduced, respectively, for lack of efficacy or side effects, but changes in active contacts, cycle time, and pulse duration were also employed. Mood or memory problems or paresthesias were the side effects most responsible for adjustments. Off‐label sites stimulated included centromedian thalamus, hippocampus, neocortex, and a few others. Several physicians used DBS in conjunction with vagus nerve stimulation or responsive neurostimulation, although our study did not track efficacy for combined use. Experienced users varied more from published parameters than did inexperienced users. In conclusion, surveys of experts can provide Class IV evidence for the most prevalent practical use of ANT‐DBS. We present a flowchart for one protocol combining common practices. Controlled comparisons will be needed to choose the best approach.
DNA Methylation Profiles of Ovarian Clear Cell Carcinoma
Cunningham, Julie M. , Winham, Stacey J. , Wang, Chen , Weiglt, Britta, Fu, Zhuxuan, Armasu, Sebastian M., McCauley, Bryan M., Brand, Alison H., Chiew, Yoke-Eng , Elishaev, Esther, Gourley, Charlie , Kennedy, Catherine J. , Laslavic, Angela, Lester, Jenny, Piskorz, Anna, Sekowska, Magdalena, Brenton, James D. , DeFazio, Anna , Drapkin, Ronny , Huntsman, David G., Köbel, Martin , Konner, Jason, Lawrenson, Kate , Papaemmanuil, Elli, Bolton, Kelly L., Goode, Ellen L., Brand, Alison H. , Fu, Zhuxuan , Churchman, Michael , Fazio, Anna de , Drapkin, Ronny , Elias, Kevin M , Karlan, Beth Y , Köbel, Martin , Lawrenson, Kate , Modugno, Francesmary , Winham, Stacey J , Brenton, James D , Wang, Chen , Kennedy, Catherine J , Fu, Zhuxuan , Brand, Alison H , Chiew, Yoke-Eng , Cunningham, Julie M , Weiglt, Britta, Fu, Zhuxuan, Armasu, Sebastian M., McCauley, Bryan M., Brand, Alison H., Elishaev, Esther, Gourley, Charlie , Laslavic, Angela, Lester, Jenny, Piskorz, Anna, Sekowska, Magdalena, Huntsman, David G., Konner, Jason, Papaemmanuil, Elli, Bolton, Kelly L., Goode, Ellen L.

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | October 25, 2021 | Volume: 31 | Issue: 1 | Pages: 132-141

10.1158/1055-9965.epi-21-0677 | PMID 34697060 Get It

Abstract Background: Ovarian clear cell carcinoma (OCCC) is a rare ovarian cancer histotype that tends to be resistant to standard platinum-based chemotherapeutics. We sought to better understand the role of DNA methylation in clinical and biological subclassification of OCCC. Methods: We interrogated genome-wide methylation using DNA from fresh frozen tumors from 271 cases, applied nonsmooth nonnegative matrix factorization (nsNMF) clustering, and evaluated clinical associations and biological pathways. Results: Two approximately equally sized clusters that associated with several clinical features were identified. Compared with Cluster 2 (N = 137), Cluster 1 cases (N = 134) presented at a more advanced stage, were less likely to be of Asian ancestry, and tended to have poorer outcomes including macroscopic residual disease following primary debulking surgery (P &lt; 0.10). Subset analyses of targeted tumor sequencing and IHC data revealed that Cluster 1 tumors showed TP53 mutation and abnormal p53 expression, and Cluster 2 tumors showed aneuploidy and ARID1A/PIK3CA mutation (P &lt; 0.05). Cluster-defining CpGs included 1,388 CpGs residing within 200 bp of the transcription start sites of 977 genes; 38% of these genes (N = 369 genes) were differentially expressed across cluster in transcriptomic subset analysis (P &lt; 10−4). Differentially expressed genes were enriched for six immune-related pathways, including IFNα and IFNγ responses (P &lt; 10−6). Conclusions: DNA methylation clusters in OCCC correlate with disease features and gene expression patterns among immune pathways. Impact: This work serves as a foundation for integrative analyses that better understand the complex biology of OCCC in an effort to improve potential for development of targeted therapeutics.
Penile Girth Injection Complications: A Case Report
Bryce, Alden Baird, Robertson, Nick, Gregory, Adam, Baird Bryce, Alden, Robertson, Nick

Mayo Clinic

Sexual Medicine | October 25, 2021 | Volume: 9 | Issue: 6 | Pages: 100445-100445

10.1016/j.esxm.2021.100445 | PMID 34695752 Get It

Abstract Introduction Penile enhancement procedures are becoming more common in men looking to achieve a more desirable penile aesthetic. We describe a case of post-procedural dermatitis after receiving penile girth enhancement injections in an adult male and discuss management of penile girth injection side effects. Materials and Methods We review and present our case alongside a discussion of girth injection complications. Results Patient's exam and symptoms improved after treatment. Conclusion Post-procedural complications after penile girth injections seem to be under-reported and unfortunately can result in severe deformity and dysfunction of the penis.
Utility of Blue Light Cystoscopy for Post-bacillus Calmette-Guérin Bladder Cancer Recurrence Detection: Implications for Clinical Trial Recruitment and Study Comparisons
Chappidi, Meera R. , Meng, Maxwell V. , Bivalacqua, Trinity J. , Holzbeierlein, Jeffrey M., Kaimakliotis, Hristos Z. , Konety, Badrinath R. , Liao, Joseph C. , Pohar, Kamal S. , Taylor, Jennifer M. , Tyson, Mark D. , Willard, Brian, Porten, Sima P. , Kates, Max , Yang, Heiko , Daneshmand, Siamak , Steinberg, Gary D. , Lotan, Yair

Mayo Clinic

Journal of Urology | October 25, 2021 | Volume: 207 | Issue: 3 | Pages: 534-540

10.1097/ju.0000000000002308 | PMID 34694916 Get It

Sex differences in the effect of acute intermittent hypoxia on respiratory modulation of sympathetic activity
Edmunds, Jane, Ivie, Clayton L., Ott, Elizabeth P., Jacob, Dain W. , Harper, Jennifer L. , Manrique‐Acevedo, Camila , Limberg, Jacqueline K. , Manrique-Acevedo, Camila M , Limberg, Jacqueline K , Baker, Sarah E.

Mayo Clinic

American Journal of Physiology-Regulatory, Integrative and Comparative Physiology | October 25, 2021 | Volume: 321 | Issue: 6 | Pages: R903-R911

10.1152/ajpregu.00042.2021 | PMID 34668438 Get It

Sex-related differences in respiratory modulation of sympathetic activity have been observed in rodent models of sleep apnea [intermittent hypoxia (IH)]. In light of sex disparities in the respiratory response to acute IH in humans as well as changes in respiratory modulation of muscle sympathetic nerve activity (MSNA) in clinical sleep apnea, we examined sex-related differences in respiratory modulation of MSNA following acute IH. We hypothesized that respiratory modulation of MSNA would be altered in both male and female participants after IH; however, the respiratory patterning of MSNA following IH would be sex specific. Heart rate, MSNA, and respiration were evaluated in healthy male ( n = 21, 30 ± 5 yr) and female ( n = 10, 28 ± 5 yr) participants during normoxic rest before and after 30 min of IH. Respiratory modulation of MSNA was assessed by fitting polynomials to cross-correlation histograms constructed between sympathetic spikes and respiration. MSNA was elevated after IH in male (20 ± 6 to 24 ± 8 bursts/min) and female (19 ± 8 to 22 ± 10 bursts/min) participants ( P < 0.01). Both male and female participants exhibited respiratory modulation of MSNA ( P < 0.01); however, the pattern differed by sex. After IH, modulation of MSNA within the breath was reduced in male participants ( P = 0.03) but increased in female participants ( P = 0.02). Both male and female adults exhibit changes in respiratory patterning of MSNA after acute IH; however, this pattern differs by sex. These data support sex disparities in respiratory modulation of MSNA and may have implications for conditions such as sleep apnea.
Silk Embolic Material for Catheter‐Directed Endovascular Drug Delivery
Hu, Jingjie , Albadawi, Hassan , Zhang, Zefu , Gündüz, Şeyda , Rehman, Suliman, d’Amone, Luciana , Mayer, Joseph L. , Omenetto, Fiorenzo G. , Öklü, Rahmi , Salomao, Marcela A, Oklu, Rahmi , Salomao, Marcela

Mayo Clinic

Advanced Materials | October 25, 2021 | Volume: 34 | Issue: 2 | Pages: No page available

10.1002/adma.202106865 | PMID 34695275 Get It

AbstractEmbolization is a catheter‐based minimally invasive procedure that deliberately occludes diseased blood vessels for treatment purposes. A novel silk‐based embolic material (SEM) that is developed and optimized to provide tandem integration of both embolization and the delivery of therapeutics is reported. Natural silk is processed into fibroin proteins of varying lengths and is combined with charged nanoclay particles to allow visibility and injectability using clinical catheters as small as 600 μm in diameter at lengths >100 cm. SEMs loaded with fluorochrome labeled bovine albumin and Nivolumab, which is among the most used immunotherapy drugs worldwide, demonstrate a sustained release profile in vitro over 28 days. In a porcine renal survival model, SEMs with labeled albumin and Nivolumab successfully embolize porcine arteries without recanalization and lead to the delivery of both albumin and Nivolumab into the interstitial space of the renal cortex. Mechanistically, it is shown that tissue delivery is most optimal when the internal elastic membrane of the embolized artery is disrupted. SEM is a potential next‐generation multifunctional embolic agent that can achieve embolization and deliver a wide range of therapeutics to treat vascular diseases including tumors.
CD36 Identifies a Subpopulation of Adipose-Derived Mesenchymal Stromal Cells with Enhanced Osteogenic Ability.
Camilleri, Emily , Riester, Scott M. , Gustafson, Michael P. , Garces, Catalina Galeano, Paradise, Christopher R. , Glusevic, Martina, Bulur, Peggy A. , Dudakovic, Amel , Dietz, Allan B. , Camilleri, Emily T. , Dietz, Allan B , van Wijnen, Andre J , Camilleri, Emily , Wijnen, André J. van

Mayo Clinic

No container title available | October 25, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-987811/v1 Get It

Abstract Background Adipose-derived mesenchymal stromal cells (AMSCs) represent attractive cellular therapeutics for treatment of various diseases including osteoarthritis and bone degeneration. Preparation and characterization of AMSCs show donor-to-donor variability that indicating that AMSCs are heterogeneous populations of cells. Cell surface markers to identify MSCs, such as CD44, CD90, and CD105, are relatively invariable among AMSCs and do not reflect the heterogeneity of AMSC populations. CD36, a multifunctional surface receptor associated with transport of oxidized low-density lipoproteins and fatty acids, is also expressed by AMSCs but this marker is considerable more variable. Therefore, we assessed whether CD36 can be used to identify subpopulations in AMSCs. Methods Clinical-grade AMSCs were isolated from patient fat biopsies, cultured under xenobiotic-free conditions using human platelet lysate and sorted by flow cytometry or magnetic cell sorting to characterize CD36 expression. CD36 enriched, CD36 depleted, and unsorted AMSCs were characterized using cellular and molecular techniques including proliferation, multilineage potential, RNA-sequencing and bioinformatics, metabolomics, and sensitivity to the CD36 inhibitor sulfosuccinimidyl oleate (SSO). Results CD36 exhibited biphasic expression on AMSCs grown in human platelet lysate. Enrichment of CD36+ AMSCs showed that CD36+ expression identifies a stable subpopulation. Transcriptomic analysis revealed enhancement of calcium transporter genes. Osteogenic differentiation of CD36+ enriched, CD36+ depleted, and unsorted AMSCs showed strikingly enhanced osteogenic calcium deposition and enhanced expression of alkaline phosphatase (ALPL) and osteoprotegrin (TNFRSF11B) in the CD36+ population. While lipid droplets were not altered, adipogenic differentiation showed upregulated gene expression of key adipogenic markers, including fatty acid-binding protein 4 (FABP4) and Adiponectin (ADIPOQ), with CD36+ enrichment. Treatment of CD36+ enriched AMSCs with the SSO showed reduced calcium deposition whereas CD36+ depleted AMSCs were unaffected. Conclusions CD36 exhibits variable expression amongst AMSCs. CD36+ enriched AMSCs are a stable subpopulation with enhanced osteogenic potential that linked to CD36 receptor function. These results may further refine production and clinical application of AMSC cellular therapeutics. Furthermore, the enhanced osteogenic potential of CD36+ AMSCs may be considered for therapeutic regeneration of bone.
Methods Used to Generate Consensus Statements for Clinical Practice Guidelines
Thompson, Jeremy C., Pinter, Zachariah W., Honig, Rachel, Tomov, Marko N., Currier, Bradford L., Elder, Benjamin D., Freedman, Brett A., Bydon, Mohamad, Sebastian, Arjun S., Thompson, Jeremy C., Pinter, Zachariah W., Honig, Rachel, Tomov, Marko N., Currier, Bradford L., Elder, Benjamin D., Freedman, Brett A., Bydon, Mohamad, Sebastian, Arjun S.

Mayo Clinic

Clinical Spine Surgery | October 25, 2021 | Volume: 34 | Issue: 10 | Pages: 391-394

10.1097/bsd.0000000000001267 | PMID 34694258 Get It

Study Design: This was a research methodology study. Objective: This review discusses the most commonly utilized consensus group methodologies for formulating clinical practice guidelines and current methods for accessing rigorous up-to-date clinical practice guidelines. Summary of Background Data: In recent years, clinical practice guidelines for the management of several conditions of the spine have emerged to provide clinicians with evidence-based best-practices. Many of these guidelines are used routinely by administrators, payers, and providers to determine the high-quality and cost-effective surgical practices. Most of these guidelines are formulated by consensus groups, which employ methodologies that are unfamiliar to most clinicians. Methods: An extensive literature review was performed. The literature was then summarized in accordance with the authors’ clinical experience. Results: The Nominal Group Technique, Delphi method, and RAND-UCLA Appropriateness Model are 3 commonly utilized consensus group methodologies employed in the creation of clinical practice guidelines. Each of these methodologies has inherent advantages and disadvantages, is dependent on rigorously performed systematic reviews and meta-analyses to inform the panel of experts, and can be used to answer challenging clinical questions that remain unanswered due to a paucity of class I evidence. Conclusions: This review highlights the most commonly utilized consensus group methodologies and informs spine surgeons regarding options to access current clinical practice guidelines. Level of Evidence: Level V.